ArticleCell reports. Medicine2025

iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors.

Bi-Huei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.